GEMWeekly (17 Nov 2023): China, Malaysia Macro; Alibaba, JD.com, Tencent
The Global Emerging Markets Weekly provides a summary of the key news and related developments impacting the largest countries and constituents of...
370 Views
[JD Health (6618 HK, BUY, TP HK$52) TP Change]: A COVID Hiccup but Environment Is Turning Positive
JDH reported lower-than-expected Q3 results, leading to reductions in profit estimates and target price, but we maintain a buy rating due to...
383 Views
[Alibaba (BABA US, SELL, TP US$72) Rating Change]: The Casualty of Era…Downgrade to SELL
Alibaba's Q3 revenue and profit were in line with expectations, but the company cancelled its spin-off plans and we have downgraded our rating to...
539 Views
[Blue Lotus Multi-Platform Sector Update]: Key JD Categories Will Grow Again in 2024
JD reported strong revenue and profit, with subsidiary JDL performing well. Growth in GMV is expected to remain steady, but may pick up in 2024....
409 Views
Alibaba, JD.com Report Double 11 Sales Growth
China’s two biggest e-commerce companies reported higher sales from this year’s Double 11 shopping extravaganza, but kept tight-lipped about just...
438 Views